Literature DB >> 4006395

Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage.

G R Matzke, J M Kovarik, M J Rybak, S C Boike.   

Abstract

Four methods of predicting vancomycin maintenance doses on the basis of the relationship between total-body or renal clearance of the drug and creatinine clearance were evaluated retrospectively using data from 24 patients who received vancomycin hydrochloride. Data for 18 men and 6 women with creatinine clearances of 10-130 mL/min were used; the mean (+/- S.D.) vancomycin maintenance dose was 22.0 +/- 11.2 mg/kg/day. The actual vancomycin maintenance dose needed to sustain an average steady-state vancomycin concentration of 15 mg/L was determined based on individual pharmacokinetic values. Predicted vancomycin maintenance doses were generated using the vancomycin-clearance:creatinine-clearance relationships derived separately by Nielsen, Moellering, Rotschafer, and Matzke. Orthogonal regression analysis was used to determine relationships between actual and predicted maintenance doses. Predictive ability of each method was assessed for bias (mean error) and precision (root mean squared error). Mean error and root mean squared error (+/- S.D.), respectively, for the four methods were as follows: Nielsen -262 +/- 451, 522 +/- 718; Moellering -91 +/- 439, 448 +/- 547; Rotschafer 192 +/- 602, 632 +/- 682; and Matzke -76 +/- 101, 408 +/- 517. Doses predicted by the Nielsen relationship were significantly lower than the actual vancomycin maintenance doses. Use of the Rotschafer relationship resulted in substantial overprediction, which increased as creatinine clearance declined. Doses predicted by the Moellering and Matzke relationships were slightly less than but not significantly different from the actual dose. The Matzke method demonstrated the least bias and was the most precise.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006395

Source DB:  PubMed          Journal:  Clin Pharm        ISSN: 0278-2677


  12 in total

1.  Application of a Bayesian method to monitor and adjust vancomycin dosage regimens.

Authors:  A K Hurst; M A Yoshinaga; G H Mitani; K A Foo; R W Jelliffe; E C Harrison
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  An updated comparison of drug dosing methods. Part IV: Vancomycin.

Authors:  R D Pryka; K A Rodvold; S M Erdman
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

3.  Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.

Authors:  Kannan Sridharan; Amal Al Daylami; Reema Ajjawi; Husain Al-Ajooz; Sindhan Veeramuthu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

Review 4.  Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.

Authors:  Christopher Giuliano; Christopher Giulano; Krystal K Haase; Ronald Hall
Journal:  Expert Rev Anti Infect Ther       Date:  2010-01       Impact factor: 5.091

Review 5.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 6.  Glycopeptides and nephrotoxicity.

Authors:  A W Chow; R M Azar
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

Review 7.  Teicoplanin in perspective. A critical comparison with vancomycin.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1991-08-23

8.  Population pharmacokinetics of vancomycin in Thai patients.

Authors:  Tunggul Adi Purwonugroho; Suvatna Chulavatnatol; Yupaporn Preechagoon; Busba Chindavijak; Kumthorn Malathum; Pakwan Bunuparadah
Journal:  ScientificWorldJournal       Date:  2012-04-01

9.  Pharmacokinetics of vancomycin in oncology egyptian paediatrics: a dosage adjustment trial.

Authors:  M A Mahmoud; A H I M Ebid; Samia A Shouman; Emad N Ebid
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

10.  Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India.

Authors:  Nitin B Mali; Siddharth P Deshpande; Poorwa P Wandalkar; Vishal A Gupta; Niteen D Karnik; Nithya J Gogtay; Gita Nataraj; Preeti R Mehta; Urmila Thatte
Journal:  Indian J Crit Care Med       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.